Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q3 2016 (← Previous) (Next →)

Filing Date: Nov 15, 2016

Total Value ($000): $57,031 (100.0% shares, 0.0% debt)

Holdings (18)

— Corbus Pharmaceuticals HLDGS 29.3%

Value ($000) $16,717 Shares 2,563,925 Est. Cost $2.53 Unrealized —

— Abeona Therapeutics Inc 14.1%

Value ($000) $8,036 Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Synthetic Biologics Inc. 11.6%

Value ($000) $6,609 Shares 3,734,149 Est. Cost $1.55 Unrealized —

— Vascular Biogenics LTD 7.7%

Value ($000) $4,406 Shares 860,605 Est. Cost $4.61 Unrealized —

— Cempra Inc 7.6%

Value ($000) $4,318 Shares 180,800 Est. Cost $31.13 Unrealized —

— Advaxis Inc. 5.0%

Value ($000) $2,857 Shares 275,000 Est. Cost $9.03 Unrealized —

— Alcobra Ltd 4.9%

Value ($000) $2,799 Shares 1,115,315 Est. Cost $7.08 Unrealized —

VNRX Volition RX LTD 4.5%

Value ($000) $2,575 Shares 461,538 Est. Cost $3.75 Unrealized +3.4%

— Ampio Pharmaceuticals Inc. 3.6%

Value ($000) $2,081 Shares 2,738,322 Est. Cost $6.03 Unrealized —

— Newlink Genetics Corp 2.6%

Value ($000) $1,504 Shares 102,437 Est. Cost $27.98 Unrealized —

ALDX Aldeyra Therapeutics Inc 1.8%

Value ($000) $1,038 Shares 135,800 Est. Cost $10.20 Unrealized -40.1%

— Keryx Biopharmaceuticals Inc. 1.8%

Value ($000) $1,030 Shares 200,000 Est. Cost $10.21 Unrealized —

— Ritter Pharmaceuticals, Inc 1.5%

Value ($000) $869 Shares 526,903 Est. Cost $1.65 Unrealized —

— Advaxis Inc. 1.3%

Value ($000) $750 Shares 112,500 Est. Cost $6.02 Unrealized —

— OHR Pharmaceutical Inc 1.0%

Value ($000) $568 Shares 205,000 Est. Cost $2.54 Unrealized —

— Bio Blast Pharma Ltd 0.7%

Value ($000) $424 Shares 250,970 Est. Cost $7.27 Unrealized —

— Caladrius Biosciences Inc 0.5%

Value ($000) $266 Shares 55,781 Est. Cost $1.87 Unrealized —

CSBR Champions Oncology INC 0.3%

Value ($000) $184 Shares 111,111 Est. Cost $4.66 Unrealized -59.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	2,563,925	$16,717	29.3%	$2.53	—	COM	21833P103
—	Abeona Therapeutics Inc	1,359,767	$8,036	14.1%	$5.06	—	COM	00289Y107
—	Synthetic Biologics Inc.	3,734,149	$6,609	11.6%	$1.55	—	COM	87164U102
—	Vascular Biogenics LTD	860,605	$4,406	7.7%	$4.61	—	COM	M96883109
—	Cempra Inc	180,800	$4,318	7.6%	$31.13	—	COM	15130J109
—	Advaxis Inc.	275,000	$2,857	5.0%	$9.03	—	COM NEW	7624208
—	Alcobra Ltd	1,115,315	$2,799	4.9%	$7.08	—	SHS	M2239P109
VNRX	Volition RX LTD	461,538	$2,575	4.5%	$3.75	+3.4%	COM	928661107
—	Ampio Pharmaceuticals Inc.	2,738,322	$2,081	3.6%	$6.03	—	COM	03209T109
—	Newlink Genetics Corp	102,437	$1,504	2.6%	$27.98	—	COM	651511107
ALDX	Aldeyra Therapeutics Inc	135,800	$1,038	1.8%	$10.20	-40.1%	COM	01438T106
—	Keryx Biopharmaceuticals Inc.	200,000	$1,030	1.8%	$10.21	—	COM	492515101
—	Ritter Pharmaceuticals, Inc	526,903	$869	1.5%	$1.65	—	COM	767836109
—	Advaxis Inc.	112,500	$750	1.3%	$6.02	—	W EXP 07/15/201	7624117
—	OHR Pharmaceutical Inc	205,000	$568	1.0%	$2.54	—	COM NEW	67778H200
—	Bio Blast Pharma Ltd	250,970	$424	0.7%	$7.27	—	SHS	M20156101
—	Caladrius Biosciences Inc	55,781	$266	0.5%	$1.87	—	COM	128058104
CSBR	Champions Oncology INC	111,111	$184	0.3%	$4.66	-59.8%	COMM NEW	15870P307